DCR Cancer Research Results
DCR, Disease control rate: Click to Expand ⟱
| Source: |
| Type: clinical outcome |
| DCR is generally calculated as:
DCR = complete response (CR) + partial response (PR) + stable disease (SD)
|
Scientific Papers found: Click to Expand⟱
DCR↑, results indicate that LMF combined with chemotarget agents significantly improved the DCR.
OS∅, OS, PFS, ORR, AEs, and QOL did not significantly differ between the two groups
PFS∅,
ORR∅,
AEs∅,
QoL∅,
OS↑, Two studies revealed a significantly longer survival time and chemotherapy treatment periods with fucoidan use.
DCR↑, Positive but insignificant effects of disease control rate, inflammatory markers, nutrition status, fatigue, and financial difficulty were shown in those using fucoidan.
Inflam↓,
fatigue↓,
ORR↑, Observed an objective remission rate (ORR) of 14.29% and an overall disease control rate (DCR) of 76.2% in arm A compare to observed an ORR of 0.00% and a DCR of 61.5% in arm B.
DCR↑,
*toxicity↓, The preliminary results of the exploratory study indicated favorable safety profiles at 45mg/m2 in this phase IIa clinical study.
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
AEs∅, 1, DCR↑, 3, ORR↑, 1, ORR∅, 1, PFS∅, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Functional Outcomes(tgid=23) ⓘ
fatigue↓, 1, OS↑, 1, OS∅, 1, QoL∅, 1,
Total Targets: 10
Pathway results for Effect on Normal Cells:
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: DCR, Disease control rate
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1558 State#:% Dir#:2
wNotes=on sortOrder:rid,rpid
Home Page